Your browser doesn't support javascript.
loading
Sacubitril-Valsartan for the Treatment of Heart Failure: Time for a Paragon?
Del Buono, Marco Giuseppe; Bonaventura, Aldo; Vecchié, Alessandra; Wohlford, George F; Dixon, Dave L; Van Tassel, Benjamin W; Abbate, Antonio.
Afiliação
  • Del Buono MG; Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Pauley Heart Center, Richmond, VA.
  • Bonaventura A; Department of Cardiovascular and Thoracic Sciences, Catholic University of the Sacred Heart, Rome, Italy.
  • Vecchié A; Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Pauley Heart Center, Richmond, VA.
  • Wohlford GF; Department of Internal Medicine, First Clinic of Internal Medicine, University of Genoa, Genoa, Italy; and.
  • Dixon DL; Division of Cardiology, Department of Internal Medicine, Virginia Commonwealth University, Pauley Heart Center, Richmond, VA.
  • Van Tassel BW; Department of Internal Medicine, First Clinic of Internal Medicine, University of Genoa, Genoa, Italy; and.
  • Abbate A; Department of Pharmacotherapy and Outcomes Science, Virginia Commonwealth University, Richmond, VA.
J Cardiovasc Pharmacol ; 75(2): 105-107, 2020 02.
Article em En | MEDLINE | ID: mdl-31815825
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Tetrazóis / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Aminobutiratos / Insuficiência Cardíaca Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Cardiovasc Pharmacol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Vaticano
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Inibidores de Proteases / Tetrazóis / Bloqueadores do Receptor Tipo 1 de Angiotensina II / Aminobutiratos / Insuficiência Cardíaca Tipo de estudo: Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: J Cardiovasc Pharmacol Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Vaticano